Strong balance sheet of $245.0 million in cash, cash equivalents and short-term investments supports operating plan through anticipated cash-flow break-even Conference call to be held today, March 9, ...

EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ARS Pharma’s partner, ALK-Abelló A/S, who owns the rights to market EURneffy in the ...

-Longer shelf life of nasal epinephrine compared with epinephrine auto-injectors translates into a more affordable, value-based price -When factoring in patients’ dislike of needle-based ...

A brief educational module for internal medicine residents was associated with improved confidence when counseling patients with food allergies on the use of self-injectable epinephrine, a small study ...

neffy is the first epinephrine product approved for use out of a hospital setting in China for adults and children (>30 kg) living with severe allergic reactions Pediatrix Therapeutics, which has a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...

The following is a summary of a story on the Student Experience website. Seth and Susan Lee’s son, Jacob, is a Duke undergrad set to graduate in May. Jacob has lived with life-threatening nut and seed ...

Thomas Jefferson University and Sempresto, Inc. are pleased to announce an exclusive licensing agreement for a novel epinephrine autoinjector designed to improve accessibility and ease of use for ...

SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves ...

In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector. (AP Photo/Rich Pedroncelli) DENVER (CN) — The 10th Circuit on Friday affirmed a denial of ...